Verona Pharma PLC Q4 2021 Earnings Call Transcript - Thomson StreetEvents

Verona Pharma PLC Q4 2021 Earnings Call Transcript

Verona Pharma PLC Q4 2021 Earnings Call Transcript - Thomson StreetEvents
Verona Pharma PLC Q4 2021 Earnings Call Transcript
Published Mar 03, 2022
9 pages (5257 words) — Published Mar 03, 2022
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Transcript of VRNA.OQ earnings conference call or presentation 3-Mar-22 2:00pm GMT

  
Brief Excerpt:

...Operator Welcome to Verona Pharma's Fourth Quarter and Year-End 2021 Financial Results and Operating Highlights Conference Call. (Operator Instructions) Earlier this morning, Verona Pharma issued a press release announcing its financial results for the 3 months and full year ended December 31, 2021. A copy can be found in the Investor Relations tab on the corporate website, www.veronapharma.com. Before we begin, I'd like to remind you that during today's call, statements about the company's future expectations, plans and prospects are forward-looking statements. These forward-looking statements are based on management's current expectations. These statements are neither promises nor guarantees and involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from our expectations, expressed or implied by the forward-looking statements, including, without limitation, the impact of COVID-19...

  
Report Type:

Transcript

Source:
Thomson StreetEvents
Company:
Verona Pharma PLC
Ticker
VRNA.OQ
Time
2:00pm GMT
Format:
PDF Adobe Acrobat
Buy Now

The following is excerpted from the question-and-answer section of the transcript.

(Questions from industry analysts are provided in full, but answers are omitted - download the transcript to see the full question-and-answer session)

Question: Andreas Argyrides - Wedbush Securities Inc., Research Division - Analyst : Two for us here. Just to start. So can you just reiterate how many of the clinical sites are in Eastern Europe and affected by the Russian conflict? And then when you're -- let's say, and you're thinking about the commercial opportunity for ensifentrine. Can you just tell us how you maybe -- remind us of the clinical -- the design of the Phase III studies are going to kind of impact the commercial strategy? And how you see it playing out in the different other -- dual or a triple therapy?

Table Of Contents

Verona Pharma PLC Corporate Call Transcript – 2022-12-20 – US$ 54.00 – Edited Transcript of VRNA.OQ conference call or presentation 20-Dec-22 8:30am GMT

Verona Pharma PLC Q3 2022 Earnings Call Transcript – 2022-11-09 – US$ 54.00 – Edited Transcript of VRNA.OQ earnings conference call or presentation 9-Nov-22 2:00pm GMT

Verona Pharma PLC Q2 2022 Earnings Call Transcript – 2022-08-09 – US$ 54.00 – Edited Transcript of VRNA.OQ earnings conference call or presentation 9-Aug-22 12:30pm GMT

Verona Pharma PLC KOL event for analysts and investors Call Transcript – 2022-06-16 – US$ 54.00 – Edited Transcript of VRNA.OQ conference call or presentation 16-Jun-22 12:00pm GMT

Verona Pharma PLC Q1 2022 Earnings Call Transcript – 2022-05-03 – US$ 54.00 – Edited Transcript of VRNA.OQ earnings conference call or presentation 3-May-22 1:00pm GMT

Verona Pharma PLC Q3 2021 Earnings Call Transcript – 2021-11-09 – US$ 54.00 – Edited Transcript of VRNA.OQ earnings conference call or presentation 9-Nov-21 2:00pm GMT

Verona Pharma PLC Q2 2021 Earnings Call Transcript – 2021-08-05 – US$ 54.00 – Edited Transcript of VRNA.OQ earnings conference call or presentation 5-Aug-21 12:30pm GMT

Verona Pharma PLC Q1 2021 Earnings Call Transcript – 2021-04-29 – US$ 54.00 – Edited Transcript of VRNA.OQ earnings conference call or presentation 29-Apr-21 1:00pm GMT

Verona Pharma PLC Annual Shareholders Meeting Transcript – 2021-04-27 – US$ 54.00 – Edited Transcript of VRNA.OQ shareholder or annual meeting 27-Apr-21 12:00pm GMT

Verona Pharma PLC Q4 2020 Earnings Call Transcript – 2021-02-25 – US$ 54.00 – Edited Transcript of VRNA.OQ earnings conference call or presentation 25-Feb-21 2:00pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "Verona Pharma PLC Q4 2021 Earnings Call Transcript" Mar 03, 2022. Alacra Store. May 15, 2025. <http://www.alacrastore.com/thomson-streetevents-transcripts/Q4-2021-Verona-Pharma-PLC-Earnings-Call-T15122644>
  
APA:
Thomson StreetEvents. (2022). Verona Pharma PLC Q4 2021 Earnings Call Transcript Mar 03, 2022. New York, NY: Alacra Store. Retrieved May 15, 2025 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Q4-2021-Verona-Pharma-PLC-Earnings-Call-T15122644>
  
US$ 54.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.